ALCHEMY PRIME LIMITED

Company number 08698974 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: Alchemy Prime Limited

1. Financial Health Score: B-

Explanation: The patient is stable and has recently recovered from a period of loss, showing improved vital signs regarding profitability and net worth. However, the significant contraction in the top line (revenue) and the dramatic reduction in overall size (total assets/liabilities) indicate that the business has undergone a strict regimen change—likely a reduction in client funds or trading volume. While the core organs (cash and equity) are currently healthy, the underlying cause of the revenue drop must be monitored to ensure it is a strategic shift rather than a symptom of market atrophy. The complex ownership structure also presents a structural anomaly that requires scrutiny.


2. Key Vital Signs

  • Pulse (Revenue/Turnover): Slowing. Turnover decreased from £8.54 million in 2024 to £6.23 million in 2025. This represents a significant 27% drop in the top line, suggesting the patient's activity levels have reduced.
  • Metabolism (Profitability): Recovered. The business swung from an operating loss of £63,113 in 2024 to an operating profit of £243,483 in 2025. The organism is now generating surplus energy rather than burning reserves.
  • Blood Pressure (Cash Position): Strong. Cash levels increased from £1.39 million to £1.84 million. The patient has excellent liquidity, ensuring short-term survival and operational flexibility.
  • Body Mass (Total Assets): Significant Weight Loss. Total assets dropped drastically from £13.6 million to £4.9 million. In a financial intermediation business, this typically indicates a reduction in client funds held or a decrease in trading positions rather than a loss of core business assets.
  • Cholesterol (Total Liabilities): Cleared. Liabilities dropped from £12.7 million to £3.4 million. This massive reduction aligns with the drop in assets, strongly suggesting the outflow of client money or the settling of counter-party positions.
  • Bone Density (Net Assets/Equity): Strengthened. Net assets increased by approximately 67%, rising from £950,685 to £1,594,168. The retained earnings have improved, strengthening the structural foundation of the business.

3. Diagnosis

Diagnosis: Post-Atrophy Strengthening with Structural Anomalies

The financial data reveals a business that has undergone a significant "slimming down." The massive simultaneous reduction in assets and liabilities (£8.6 million drop in assets vs £9.3 million drop in liabilities) is the most critical symptom. For a company in "Activities auxiliary to financial intermediation" (FX & CFD trading), this pattern is characteristic of a reduction in client deposits or trading volume. Client money is typically held as an asset (cash) and a corresponding liability (money owed to clients); when clients withdraw or trade less, both sides of the balance sheet shrink.

Despite this "weight loss," the patient's vital functions have improved. The shift to profitability and the increase in net assets suggest that while there is less money passing through the system, the company is retaining a better percentage of it. The "blood flow" (cash) remains robust at £1.84 million, covering current liabilities comfortably.

However, there is a structural anomaly in the governance. The People with Significant Control (PSC) register lists three corporate entities (Fdctech Inc, Sync Capital Limited, Apsi Holdings Limited) all owning more than 75% of the company, alongside individual owners with significant stakes. This is mathematically impossible unless these entities are part of a chain or there are overlapping legal arrangements. This "genetic" complexity could pose a risk to decision-making clarity or suggest a group restructuring that isn't immediately transparent.


4. Recommendations

  1. Investigate the Revenue Decline: The 27% drop in turnover is the most concerning symptom. Management must diagnose whether this is due to market conditions, client attrition, or a strategic withdrawal from unprofitable trading volumes. A continued decline could threaten the newly regained profitability.
  2. Monitor the "Slimming" Trend: While reducing liabilities is generally positive, the scale of the balance sheet contraction needs context. Ensure that the reduction in client money does not indicate a loss of market share or platform competitiveness.
  3. Clarify Ownership Structure: The PSC register appears contradictory. It is recommended that the filings be reviewed to ensure they accurately reflect the legal ownership chain, preventing potential compliance issues with Companies House.
  4. Maintain Liquidity Buffers: Given the volatility inherent in the CFD trading sector, the current healthy cash position should be maintained as a buffer against market and counterparty risks, as identified in the strategic report.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 28 August 2026